Log In
Print
BCIQ
Print
Print this Print this
 

AzaSite Xtra (ISV-405)

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
DescriptionDurasite formulation of azithromycin (2%)
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat ocular infections
Regulatory Designation

Partner

Senju Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today